Gadobenate Intravenous and Kisqali (600 MG Dose)
Determining the interaction of Gadobenate Intravenous and Kisqali (600 MG Dose) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: gadobenate dimeglumine
Brand name: Multihance
Synonyms: Gadobenate dimeglumine, Gadobenate Dimeglumine
Generic Name: ribociclib
Brand name: Kisqali
Synonyms: Kisqali
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Gadobenate Intravenous-Kisqali Femara Co-Pack
- Gadobenate Intravenous-Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
- Gadobenate Intravenous-Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
- Gadobenate Intravenous-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Gadobenate Intravenous-Kitabis Pak
- Gadobenate Intravenous-Kitabis Pak inhalation
- Kisqali (600 MG Dose)-Gadobutrol
- Kisqali (600 MG Dose)-Gadobutrol Intravenous
- Kisqali (600 MG Dose)-Gadodiamide
- Kisqali (600 MG Dose)-Gadodiamide Intravenous
- Kisqali (600 MG Dose)-Gadofosveset
- Kisqali (600 MG Dose)-Gadofosveset Injection